This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims include assessing changes in body composition, metabolic biomarkers, inflammation, gut microbiome composition, patient-reported outcomes, and clinician-reported surgical recovery metrics.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
20
A two-week cyclic menu (14 unique days of meals repeated) approach will be used for the Mediterranean diet intervention. Participants will be provided with 3 meals a day and receive daily snacks to consume.
Moffitt Cancer Center
Tampa, Florida, United States
Feasibility of Enrollment
Percentage of eligible participants who enroll.
Time frame: Up to 1 year
Retention
Percentage of enrolled participants will complete assessments at both timepoints
Time frame: 8 weeks post-surgery
Adherence
Percentage of participants who consume ≥70% of study meals.
Time frame: At 4 weeks.
Acceptability
Percentage of participants who rate overall satisfaction as "agree" and "strongly agree."
Time frame: 8 weeks post-surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.